Showing results (1-10 of 78) with videos related to
Sort By:
Pageof 8
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 12, 2018
[Adverse events of ABL tyrosine kinase inhibitors in chronic myeloid leukemia therapy]Tetsuzo TauchiLeukemia Research|March 24, 2004
Molecular mechanisms of resistance of leukemia to imatinib mesylateTetsuzo Tauchi, Kazuma OhyashikiInternational Journal of Hematology|June 8, 2006
The second generation of BCR-ABL tyrosine kinase inhibitorsTetsuzo Tauchi, Kazuma OhyashikiGan to Kagaku Ryoho. Cancer & Chemotherapy|August 27, 2003
[Molecular-target therapy of Ph-positive leukemia by imatinib (tyrosine kinase inhibitor)]Tetsuzo Tauchi, Kazuma OhyashikiInternational Journal of Hematology|July 9, 2004
Imatinib mesylate in combination with other chemotherapeutic agents for chronic myelogenous leukemiaTetsuzo Tauchi, Kazuma OhyashikiClinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Characteristics of dasatinib- and imatinib-resistant chronic myelogenous leukemia cellsSeiichi Okabe, Tetsuzo Tauchi, Kazuma Ohyashiki[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 20, 2009
[Molecular relapse of chronic myeloid leukemia after discontinuation of imatinib mesylate for maintaining complete molecular response for more than 2 years]Toru Kiguchi, Tetsuzo Tauchi, Kazuma OhyashikiExperimental Hematology|May 18, 2010
Establishment of a new Philadelphia chromosome-positive acute lymphoblastic leukemia cell line (SK-9) with T315I mutationSeiichi Okabe, Tetsuzo Tauchi, Kazuma OhyashikiAnnals of Hematology|June 22, 2010
Efficacy of MK-0457 and in combination with vorinostat against Philadelphia chromosome positive acute lymphoblastic leukemia cellsSeiichi Okabe, Tetsuzo Tauchi, Kazuma OhyashikiMethods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Telomerase inhibition combined with other chemotherapeutic reagents to enhance anti-cancer effectTetsuzo Tauchi, Junko H Ohyashiki, Kazuma OhyashikiPageof 8